Search research articles
Contact Us
Filters
Showing results (391-400 of 518) with videos related to
Page
of 52
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2013
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates
Belinda E Kiely, Andrew J Martin, Martin H N Tattersall, et al.
Asia-Pacific Journal of Clinical Oncology
|
July 7, 2023
C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients
Vanessa F Bonazzi, Lauren G Aoude, Sandra Brosda, et al.
BMC Cancer
|
April 25, 2018
The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer
Megan Best, Ainsley J Newson, Bettina Meiser, et al.
BMC Cancer
|
April 7, 2018
The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling
Megan Best, Ainsley J Newson, Bettina Meiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
Malcolm J Moore, David Goldstein, John Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2023
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Malcolm J Moore, David Goldstein, John Hamm, et al.
Oral Oncology
|
July 18, 2016
A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer
Sjoukje F Oosting, Tom W W Chen, Shao H Huang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 15, 2022
Prognostic models to predict survival in patients with pancreatic cancer: a systematic review
Liane J Ioannou, Ashika D Maharaj, John R Zalcberg, et al.
Cancer Epidemiology
|
November 5, 2013
The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre
Steven Habbous, Karen P Chu, Xin Qiu, et al.
Oral Oncology
|
October 20, 2012
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure
Andrew K Chan, Shao Hui Huang, Lisa W Le, et al.
Page
of 52
Search research articles
Search
Showing results (391-400 of 518) with videos related to
Sort By:
Page
of 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 5, 2013
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimates
Belinda E Kiely, Andrew J Martin, Martin H N Tattersall, et al.
Asia-Pacific Journal of Clinical Oncology
|
July 7, 2023
C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients
Vanessa F Bonazzi, Lauren G Aoude, Sandra Brosda, et al.
BMC Cancer
|
April 25, 2018
The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer
Megan Best, Ainsley J Newson, Bettina Meiser, et al.
BMC Cancer
|
April 7, 2018
The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling
Megan Best, Ainsley J Newson, Bettina Meiser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2007
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
Malcolm J Moore, David Goldstein, John Hamm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2023
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Malcolm J Moore, David Goldstein, John Hamm, et al.
Oral Oncology
|
July 18, 2016
A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer
Sjoukje F Oosting, Tom W W Chen, Shao H Huang, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
March 15, 2022
Prognostic models to predict survival in patients with pancreatic cancer: a systematic review
Liane J Ioannou, Ashika D Maharaj, John R Zalcberg, et al.
Cancer Epidemiology
|
November 5, 2013
The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre
Steven Habbous, Karen P Chu, Xin Qiu, et al.
Oral Oncology
|
October 20, 2012
Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure
Andrew K Chan, Shao Hui Huang, Lisa W Le, et al.
Page
of 52